The main finding when studying the secretion and action of incretin hormones (glucose-dependent insulinotropic polypeptide [GIP] and GLP-1) in individuals with type 2 diabetes is a reduced incretin effect. This evidence concerns the gene GCG and type 2 diabetes mellitus.